Transaction #6051 · Form 4 · 0001193125-25-272572
CORCEPT THERAPEUTICS INC · Exercise / conversion · Common Stock
CORCEPT THERAPEUTICS INC · Transacted November 5, 2025 · Filed November 7, 2025
What does this filing report?
An SEC Form 4 filing for CORCEPT THERAPEUTICS INC records an exercise / conversion involving Common Stock on November 5, 2025. The reported quantity was 20,000. The filing date is November 7, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CORCEPT THERAPEUTICS INC
- Company CIK
- 0001088856
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 20,000
- Reported price
- 21.65
- Reference value
- 433,000
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 25,287
- Ownership description
- Not reported
- SEC acceptance time
- Nov 7, 2025, 5:10 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Guyer William ↗
Chief Development Officer
CIK 0001879013
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- F2
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.17 to $75.165 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F3
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $75.185 to $76.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- F4
- Fully exercisable.
Remarks
The power of attorney under which this form was signed is on file with the Commission.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.